New jerseylondon

PRINCETON, New Jersey and LONDON - Results from an 18-week phase 3b study in adults with type 2 diabetes with inadequate glycemic control on metformin therapy alone found that the addition of treatment with ONGLYZA(TM) (saxagliptin) 5 mg per day achieved the primary objective of demonstrating non-inferiority compared to the addition of treatment with JANUVIA(R) (sitagliptin) 100 mg per day in reducing HbA1c from baseline.

JERSEY CITY, New Jersey and LONDON - Knight Capital Group, Inc.

JERSEY CITY, New Jersey and LONDON - Knight Capital Group, Inc.

JERSEY CITY, New Jersey and LONDON - Knight Capital Group, Inc.